Explore more publications!

The France Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The France Journal.

Press releases published on February 27, 2026

Green Globe Gold Awarded to Hotel Barrière Le Majestic Cannes
La nouvelle version du protocole de ville intelligente continue de renforcer l’interopérabilité
Tagshop AI Expands AI Ad Creation With Kling 3.0, Seedance Models, New Templates, and Upcoming AI Ad Clone Feature
The First 30 Educational Stages of WMF2026: the World’s Most Comprehensive Educational Program in AI, Digital, and Tech
6WIND Expands VSR Deployment to NVIDIA BlueField-3 DPUs for Cloud, Telco, and AI Infrastructure
EFESO presents the winners of the INDUSTRIE 4.0 AWARD 2025
[Press Release] Sale of 80% of Ipsos Comcon LLC - Ipsos’ subsidiary in Russia
Atos named a Leader in ISG Provider Lens™ 2025 for Cybersecurity – Services and Solutions in the United States
Communiqué de presse : Dupixent de Sanofi et Regeneron recommandé pour approbation dans l'UE dans le traitement de l'urticaire chronique spontanée chez les jeunes enfants dont les symptômes persistent malgré un traitement
Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment
Ipsen receives positive CHMP opinion for Ojemda® for the treatment as monotherapy of children with relapsed or refractory BRAF-altered pediatric low-grade glioma
Ipsen reçoit un avis positif du CHMP pour Ojemda® en monothérapie pour le traitement des enfants atteints de gliome pédiatrique de bas grade en rechute ou réfractaire, avec altération de BRAF
Press Release: Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness
Communiqué de presse: L’acoziborole Winthrop, développé par DNDi et Sanofi, reçoit l’avis positif du CHMP comme traitement à dose unique à trois comprimés pour la forme la plus fréquente de la maladie du sommeil
Vallourec Fourth Quarter 2025 Results
Résultats du Quatrième Trimestre 2025

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions